Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.
The closing price of Castle Biosciences Inc (NASDAQ: CSTL) was $18.91 for the day, up 2.00% from the previous closing price of $18.54. In other words, the price has increased by $2.00 from its previous closing price. On the day, 0.34 million shares were traded. CSTL stock price reached its highest trading level at $19.0625 during the session, while it also had its lowest trading level at $17.8862.
Ratios:
Our analysis of CSTL’s different ratios will help us gain a deeper understanding of the company. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 1.98 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 11.27. For the most recent quarter (mrq), Quick Ratio is recorded 9.19 and its Current Ratio is at 9.37. In the meantime, Its Debt-to-Equity ratio is 0.06 whereas as Long-Term Debt/Eq ratio is at 0.05.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Guggenheim on December 14, 2023, initiated with a Buy rating and assigned the stock a target price of $25.
On January 05, 2023, Scotiabank started tracking the stock assigning a Sector Outperform rating and target price of $54.
On January 07, 2022, Stephens started tracking the stock assigning a Overweight rating and target price of $59.Stephens initiated its Overweight rating on January 07, 2022, with a $59 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Apr 21 ’25 when MAETZOLD DEREK J sold 4,408 shares for $21.52 per share. The transaction valued at 94,851 led to the insider holds 4,275 shares of the business.
MAETZOLD DEREK J sold 1,236 shares of CSTL for $26,596 on Apr 21 ’25. The Pres. & Chief Exec. Officer now owns 74,627 shares after completing the transaction at $21.52 per share. On Apr 09 ’25, another insider, MAETZOLD DEREK J, who serves as the Pres. & Chief Exec. Officer of the company, sold 3,647 shares for $20.22 each. As a result, the insider received 73,739 and left with 4,440 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CSTL now has a Market Capitalization of 545975168 and an Enterprise Value of 296668480. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.57 while its Price-to-Book (P/B) ratio in mrq is 1.24. Its current Enterprise Value per Revenue stands at 0.855 whereas that against EBITDA is 10.361.
Stock Price History:
The Beta on a monthly basis for CSTL is 1.04, which has changed by -0.1025154 over the last 52 weeks, in comparison to a change of 0.092761636 over the same period for the S&P500. Over the past 52 weeks, CSTL has reached a high of $35.84, while it has fallen to a 52-week low of $15.45. The 50-Day Moving Average of the stock is 3.39%, while the 200-Day Moving Average is calculated to be -25.42%.
Shares Statistics:
CSTL traded an average of 430.14K shares per day over the past three months and 449730 shares per day over the past ten days. A total of 28.84M shares are outstanding, with a floating share count of 27.94M. Insiders hold about 3.21% of the company’s shares, while institutions hold 91.53% stake in the company. Shares short for CSTL as of 1748563200 were 1256286 with a Short Ratio of 2.92, compared to 1745971200 on 1513207. Therefore, it implies a Short% of Shares Outstanding of 1256286 and a Short% of Float of 4.9799999999999995.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
